February 13-14, 2012 BIO CEO Investor Conference
The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Because their mission is to […]
Protected: Smart Stocks Watch: Stellar Pharmaceuticals — Migraines, Pain, Urology, Dermatology, Cardiology
There is no excerpt because this is a protected post.
James Huang, China Forum II Co-Chair, Investigates the Big Trends in Chinese Healthcare
American firms looking to expand into China face some challenges and Huang dissects strategies to navigate this complex process.
Editor’s Note December 20, 2012
With a new year upon us, we are reminded of the year that is now coming to a close. 2011 has brought some amazing advancements […]
Mirna Therapeutics Uses Synthetic miRNA to Fight Disease
Researchers discovered that miRNA plays an important role in a process known as transcription. .Since its miRNA is a mimic, it has the same sequence as the natural miRNA found in cells.
Excelimmune Optimizes the Natural Power of the Immune System
MRSA, which is commonly acquired through contact within the community, is resistant to most first-line antimicrobials on the market.
Biovista’s Drug Repositioning Program Creates a Pipeline of New Drugs from Existing Ones
Clinical Outcome Search Space (COSS) uses the Mechanism of Action approach to find additional uses for current medications.
This Week in Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
CVAC Wellness Systems Has Developed a Natural Method for Enhancing Physical Condition
CVAC Wellness Systems will be presenting its products and technologies at OneMedForum SF 2012, on January 9 – 12
BMEYE Products Provide Fast, Easily Obtained Diagnosis to Improve Patient Care
The company has developed two products that have been given approval to be marketed by U.S. and European regulatory agencies